Indaptus Therapeutics, Inc.
INDP
$2.51
$0.4320.67%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -15.42M | -18.86M | -20.85M | -16.87M | -16.96M |
| Total Depreciation and Amortization | -- | -- | -- | 0.00 | 0.00 |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.88M | 2.91M | 2.51M | 2.03M | 1.96M |
| Change in Net Operating Assets | -1.15M | -836.50K | 3.51M | -190.70K | 29.70K |
| Cash from Operations | -14.70M | -16.79M | -14.82M | -15.03M | -14.97M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -4.00M | -- | -- | -- | -- |
| Cash from Investing | -4.00M | -- | -- | -- | -- |
| Total Debt Issued | 0.00 | 5.71M | 5.71M | 5.71M | 5.71M |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 14.34M | 2.92M | 6.40M | 8.53M | 9.19M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | 6.00M | 6.00M | 6.00M | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -249.50K | -238.30K | -569.60K | -773.50K | -1.08M |
| Cash from Financing | 20.09M | 14.39M | 17.54M | 13.47M | 13.83M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.40M | -2.39M | 2.72M | -1.56M | -1.14M |